Table of Contents

• 1.   Market Introduction
  •   1. Objectives of the Study
      2. Market Definition
      3. Market Scope
       3.1. Years Considered for the Study
       3.2. Market Covered
      4. Currency
      5. Limitations
      6. Stakeholders
    
• 2.   Research Methodology
  •   1. Research Data
       1.1. Secondary Data
        1.1.1. Key Data from Secondary Sources
       1.2. Primary Data
        1.2.1. Key Data from Primary Sources
      2. Market Size Estimation
      3. Market Breakdown and Data Triangulation
      4. Assumptions for the Study
    
• 3.   Executive Summary

  •   1. Market Outlook
      2. Segment Outlook
      3. Competitive Insights

• 4.   U.S. Anesthesiology Service Market Variables, Trends & Scope

  •         1. Market Lineage Outlook
            2. Penetration and Growth Prospect Mapping
            3. Industry Value Chain Analysis
            4. Cost Analysis Breakdown
            5. Technology Overview
            6. Regulatory Framework
                 6.1. Reimbursement Framework
                 6.2. Standards and Compliances

• 5.   Market Overview

  •      1. Market Dynamics
            1.1. Market Driver Analysis
                1.1.1. Increasing focus of Point-Of-Care Coagulation Testing Devices Companies on Brand Protection
                1.1.2. Untapped Opportunities in Emerging Regions
            1.2. Market Restraint Analysis
                1.2.1. High Cost Associated with Implementation of Predictive Analysis
            1.3. Industry Challenges
                1.3.1. Presence of Ambiguous Regulatory Framework

• 6.  U.S. Anesthesiology Service Market Analysis Tools

  • 1. Industry Analysis - Porter’s
            1.1. Supplier Power
            1.2. Buyer Power
            1.3. Substitution Threat
            1.4. Threat from New Entrants
            1.5. Competitive Rivalry
    2. Pestel Analysis
            2.1. Political Landscape
            2.2. Environmental Landscape
            2.3. Social Landscape
            2.4. Technology Landscape
            2.5. Legal Landscape
    3. Major Deals And Strategic Alliances Analysis
            3.1. Joint Ventures
            3.2. Mergers and Acquisitions
            3.3. Licensing and Partnership
            3.4. Technology Collaborations
            3.5. Strategic Divestments
    4. Market Entry Strategies
    5. Case Studies

• 7.  U.S. Anesthesiology Service Market, By Type Historical Analysis and Forecast 2024-2032 (USD Million)

  • 1. Anesthesia Medications
    2. Others

• 8.  U.S. Anesthesiology Service Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)

  • 1. Gastroenterological Focused Ambulatory Surgical Center (GIASC)
    2. Others

• 9.  Market Share Analysis and Competitive Landscape

  • 1. Market Landscape - Key Players, Revenue and Presence
    2. Market Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    3. Emerging Companies
    4. U.S. - Market Share Analysis and Key Regional Players
    5. Key Player - Growth Matrix

• 10.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

  •          1. Abeo
                1.1. Company Overview
                1.2. Product Portfolio
                1.3. SWOT Analysis
                1.4. Financial Overview
                1.5. Strategic Overview
             2. AnesthesiaBillingBridge
                2.1. Company Overview
                2.2. Product Portfolio
                2.3. SWOT Analysis
                2.4. Financial Overview
                2.5. Strategic Overview
            3. Blackstone (TeamHealth)
                3.1. Company Overview
                3.2. Product Portfolio
                3.3. SWOT Analysis
                3.4. Financial Overview
                3.5. Strategic Overview
           4. Freelance Anesthesia
                4.1. Company Overview
                4.2. Product Portfolio
                4.3. SWOT Analysis
                4.4. Financial Overview
                4.5. Strategic Overview
            5. KKRCo. Inc. (Envision Healthcare Corporation)
                5.1. Company Overview
                5.2. Product Portfolio
                5.3. SWOT Analysis
                5.4. Financial Overview
                5.5. Strategic Overview
            6. Mednax
               6. 1. Company Overview
               6. 2. Product Portfolio
               6. 3. SWOT Analysis
               6. 4. Financial Overview
               6.5. Strategic Overview
            7. National Anesthesia Services
                7.1. Company Overview
                7.2. Product Portfolio
                7.3. SWOT Analysis
                7.4. Financial Overview
                7.5. Strategic Overview
            8. PhyMed Healthcare Group
                8.1. Company Overview
                8.2. Product Portfolio
                8.3. SWOT Analysis
                8.4. Financial Overview
                8.5. Strategic Overview
            9. Somnia Anesthesia
                9.1. Company Overview
                9.2. Product Portfolio
                9.3. SWOT Analysis
                9.4. Financial Overview
                9.5. Strategic Overview
           10. Xenon Health
                10.1. Company Overview
                10.2. Product Portfolio
                10.3. SWOT Analysis
                10.4. Financial Overview
                10.5. Strategic Overview

• 11.  Pre and Post COVID-19 Impact

  • 1. Positive influence on the healthcare industry
    2. The financial disruption of the manufacturing sector
    3. Impact of COVID-19 on emerging companies
    4. Significant mandates in the healthcare regulations initiated by administrations
    5. The overall economic slowdown of the developing and developed nations

• 12.  FutureWise SME Key Takeaway Points for Client

  • .